rs61733029
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The ENST00000199280.4(AQP2):c.39G>A(p.Val13=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0066 in 1,613,494 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0055 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0067 ( 51 hom. )
Consequence
AQP2
ENST00000199280.4 synonymous
ENST00000199280.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.55
Genes affected
AQP2 (HGNC:634): (aquaporin 2) This gene encodes a water channel protein located in the kidney collecting tubule. It belongs to the MIP/aquaporin family, some members of which are clustered together on chromosome 12q13. Mutations in this gene have been linked to autosomal dominant and recessive forms of nephrogenic diabetes insipidus. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 12-49950869-G-A is Benign according to our data. Variant chr12-49950869-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 256244.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-49950869-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.55 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0055 (838/152400) while in subpopulation AMR AF= 0.0104 (160/15314). AF 95% confidence interval is 0.00913. There are 2 homozygotes in gnomad4. There are 399 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AQP2 | NM_000486.6 | c.39G>A | p.Val13= | synonymous_variant | 1/4 | ENST00000199280.4 | NP_000477.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AQP2 | ENST00000199280.4 | c.39G>A | p.Val13= | synonymous_variant | 1/4 | 1 | NM_000486.6 | ENSP00000199280 | P1 | |
AQP2 | ENST00000550862.1 | c.39G>A | p.Val13= | synonymous_variant | 1/3 | 5 | ENSP00000450022 | |||
AQP2 | ENST00000551526.5 | c.39G>A | p.Val13= | synonymous_variant, NMD_transcript_variant | 1/6 | 5 | ENSP00000447148 |
Frequencies
GnomAD3 genomes AF: 0.00550 AC: 837AN: 152282Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
837
AN:
152282
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00590 AC: 1482AN: 251302Hom.: 8 AF XY: 0.00637 AC XY: 865AN XY: 135846
GnomAD3 exomes
AF:
AC:
1482
AN:
251302
Hom.:
AF XY:
AC XY:
865
AN XY:
135846
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00672 AC: 9818AN: 1461094Hom.: 51 Cov.: 31 AF XY: 0.00690 AC XY: 5013AN XY: 726668
GnomAD4 exome
AF:
AC:
9818
AN:
1461094
Hom.:
Cov.:
31
AF XY:
AC XY:
5013
AN XY:
726668
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00550 AC: 838AN: 152400Hom.: 2 Cov.: 33 AF XY: 0.00535 AC XY: 399AN XY: 74538
GnomAD4 genome
AF:
AC:
838
AN:
152400
Hom.:
Cov.:
33
AF XY:
AC XY:
399
AN XY:
74538
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | AQP2: BP4, BP7, BS1, BS2 - |
Diabetes insipidus, nephrogenic, autosomal Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Nephrogenic diabetes insipidus Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 28, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at